Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks.
Hi Georgie. Any news Re : $HSDT ? TIA GLTA $HSDT
$CEMI Which broker are you using? TIA $CEMI
More like a $260M day. $ECMH GLTA
Started to move.
$ECMH Agree. Short squeeze soon. $ECMH GLTA
Thanks.
King
Quote :
"The recovery from early year lows here has been quite spectacular resulting in a current mcap of $43.82 Billion! A very exciting and high growth area to work in with future growth in CTV only going to accelerate over coming years."
Now that price is down almost 50%,
here is your second chance.
Are you all in?
$TTD GLTA
Hi King. Which broker are you using to buy and sell premarket? Do they charge commission fees per transaction? TIA
Hi King. Which broker are you using to buy and sell premarket? Do they charge commission fees per transaction? TIA
Well Big, it broke $1.43 Now it is $1.71 Congrats. Off to the races we go. GLTA $CRBP
If I may ask,
Are you invested in GE?
You are welcome.
$IMV Good call, it hit +$9 premarket today. GLTA $IMV
$EVFM +$8 Pre market Up 63% FDA approval for gel contraceptive $EVFM GLTA
Yes they are :
BodySphere’s 2-minute coronavirus test gets FDA emergency clearance
BodySphere said its tests have a 91 percent clinical specificity rate and a 99 percent clinical sensitivity rate.
BODYSPHERE
I-Chun Chen, ReporterMar 31, 2020, 2:02pm PDT
Los Angeles-based BodySphere Inc. said it has been cleared to distribute its new two-minute COVID-19 testing kit and has contracted cargo planes to deliver the product to the front lines of health care facilities.
The U.S. Food and Drug Administration has issued Emergency Use Authorization for the company’s test which uses antibodies in blood to test for current or past infection.
BodySphere said its tests have a 91 percent clinical specificity rate and a 99 percent clinical sensitivity rate.
Results are delivered on site in as fast as two minutes, rather than current COVID-19 tests, which take two to seven days for results. In addition, the test can be administered as easily as a glucose test but is designed strictly for use by medical professionals, the company said.
BodySphere is led by Chief Executive Charlton Lui, a tech veteran who worked with Bill Gates to develop the tablet PC. Lui also has worked at Apple (Nasdaq: AAPL) and Stanford Research Institute, and co-founded Truetype font and the first multi-media internet conferencing.
“When we realized we had the ability to step up and fight this pandemic at a critical point, we focused all our resources on bringing the rapid test kits, masks and other critical supplies to the front lines as soon as possible.” Lui said in a statement. “Thankfully, when our perpetual quest for improving health put us in a position to deliver this lifesaving product – it became quite clear what we had to do.”
BodySphere said its test kits have been used successfully in several states where large roll outs are planned. It also is working closely with federal agencies and states to quickly deploy test kits across the country to hospitals, urgent care and emergency rooms. The company said it is positioned to have millions of test kits on the front lines in weeks.
Most probably :
The Food and Drug Administration issued emergency approval to a two-minute test for coronavirus, its maker, Bodysphere Inc., said Tuesday.
The move could help increase the U.S. testing capability, which has been improving but is still not where it needs to be, according to governors.
"Results are delivered on site in as fast as two minutes," Bodysphere said in a press release. "This is a game changer as today in the United States, most COVID-19 testing results take between two to seven days."
The importer is Healgen Scientific of Houston, TX. This is the wholly owned subsidiary of the manufacturer, ZOG. It has nothing to do with AYTU. Good find. Well done.
If ZOG is the manufacturer and Healgen is ZOG'S USA, wholly owned subsidiary based in Houston,TX. I talked to Healgen and asked them if AYTU is their exclusive distributor in the USA, Healgen answer to me was shocking
" Never heard of them". Healgen also informed me that ZOG has a distributor called CONFIRM out of San Diego, CA. I checked Confirm's website and sure rnough they are advertising ZOG Covid 19 test kits. I sold my shares Friday. My question is how can a company in Hong Kong, which is not the principal, or the USA wholly owned subsidiary appoint an exclusive agent in a territory it does not own? My other question to you : Why didn't AYTU deliver any product to Colorado or any other state so far? They announced that a shipment is on its way. Why didn't they keep their promise? It is stinky. I smell scam. Guys do your own DD and reach your own conclusions. You can contact Healgen in Houston, TX, and Confirm in San Diego, CA
This is from LB Resources website:
PRAGMATIC ACTIONS DELIVER RESULTS
INTERNET & AI TECHNOLOGY COMPLIMENTING PRAGMATIC APPROACH TODELIVER RESULTS Leveraging on our experience and knowledge acquired over 30 years in the complete cycle of Commerce, from the specific engagements in the various countries we provided our services, enable us to effectively address your needs and deliver the results. Our engagements have covered product development, manufacturing, corporate finance/capital raising/IPO, commodities supply chain management, logistics arrangements, marketing & distribution, business investigative work to turnkey project management. We co-operate and work with all parties involved with pragmatic handling which is the key to deliver the results.
WE DELIVER WHEN OTHERS FAIL!Established in 1987, led by our Principal, L.B.Saw,he and his team of professionals have over 200 years of collective knowledge and experience in all aspects of Commerce. With over 30 years of engagements in various industries, we are able to provide our services to businesses based on our pragmatic and realistic approaches. We are able to share and contribute our in-depth knowhow with our clients to achieve their needs in an expeditious manner and save them from expensive pitfalls.
Our services cover -
* Business Development, Project Management & Investment; * Analysis & Research, Budget review; * Provide guidance on Local Laws and its Applications;* Monitoring processes from start to end points for each transaction; * Shipping & Logistics expertise; * Trade documentation; * Investigation, field audit and assessment work on projects; * Due diligence and verification. Fraud Prevention; * Business management, legal compliance, consultancy & advice.
Extensive affiliation with business community in Asia : WE WORKED CLOSELY WITH EXPERIENCED PROFESSIONALS IN EACH LOCATION.
Thanks for the update.
I am out of here. Please let me know when you hear from her. What worried me was that : They had three offerings. They never announced receipt of the test kits they claimed they shipped, they never followed with the Gov. of Colorado. They never announced final approval by the FDA. They never announced selling any products. The last red flag was when the Ihub poster mentioned Healgen, is a wholly owned susidiary of the Chinese manufacturer. Thanks to him and to you.
My gut feeling was different. I am out of here. Thanks for the response.
I called Healgen,their wholly owned subsidary in Houston, and asked them whether AYTU is an exclusive distributor for USA. T
heir answer shocked me :
"Never heard of them"
Then I asked if they have any distributor in the USA. They answered yes.
You are probably right. Thanks.
$AYTU AH it hit the range
$2.12 - $2.14 Gapping up premarket, tomorrow morning
GLTA $AYTU
Good deal. Thanks.
GLTA
$AYTU
This field is getting crowded. Whoever reaches the finish line wins the race. $AYTU, hurry up.
From :Crunchbase Daily
Telehealth Startup Nurx Rolling Out At-Home Test For COVID-19
Sophia Kunthara
March 20, 2020
Nurx, the telehealth startup known for delivering birth control and at-home sexually transmitted infection testing, is rolling out a home test for COVID-19.
The company’s long-time partner, Molecular Testing Labs, is developing the test, which will be available as soon as Friday afternoon.
“Drive-through testing is an option, but it doesn’t exist everywhere,” Dr. Chris Hall, Nurx’s senior medical adviser said in an interview with Crunchbase News. “We feel that all of the testing options are necessary to address this crisis, but we just feel like home-based testing is going to be a really important part of that.”
Nurx, which is based in San Francisco, has more than $93 million in funding and is backed by investors including Kleiner Perkinsand Union Square Ventures. It last raised $32 million for its Series C round in August 2019.
Nurx first published a blog post to answer a few questions about coronavirus, before the company realized it could play a bigger role in the solution. The startup has been working for about two weeks on making an at-home test available, Hall said, and has been meeting with Molecular Testing Labs multiple times every day, including weekends. The entire Nurx team has been working on rolling out the at-home COVID-19 test.
“We began to realize pretty quickly after creating that blog post that we were perfectly situated to pivot to this service,” he said.
While Nurx is perhaps best known for delivering birth control and the HIV-prevention medication PrEP, it has been in the at-home testing space for a while, providing testing kits for sexually transmitted infections, HIV, Hepatitis C and HPV.
Getting tested for coronavirus in the United States has been difficult, and Nurx is one of several startups working on making more COVID-19 tests available since the Food and Drug Administration gave certified labs the green light to develop and distribute them. Austin-based at-home testing startup EverlyWellalso announced plans to have an at-home COVID-19 test available next week. Los Angeles’ Scanwell Healthand San Francisco’s Carbon Health also announced home test kits.
A person wanting to get tested for the virus can use the Nurx app or website, indicate interest in the test and fill out a survey with questions about symptoms. A Nurx provider will then review the information and decide if the patient should be tested. If so, the company will send a test kit with expedited shipping and instructions on how to complete the test and how to send the kit back to Molecular Testing Labs’ facility in Vancouver, Washington.
To complete the test, patients will perform a throat swab. Molecular Testing Labs performs a polymerase chase reaction (PCR) test to determine if the patient has COVID-19.
A patient should receive results within 24 to 48 hours, Hall said, and Nurx will advise them what next steps they should take, such as isolation. Patients will receive automatic advice, but if they have unanswered questions they can communicate with a provider.
Nurx will have the test, which will cost under $200, available on a “limited basis” when it’s first introduced. The company’s planning to provide 10,000 home testing kits in the upcoming weeks and, according to a company spokeswoman, 100,000 tests in the near future.
“We are here to work with everyone just to increase the sheer number of tests that are out there,” Hall said. “No single provider and no single company or initiative is going to be able to solve this problem alone.”
Editor’s note: This article was updated post-publication to reflect that patients will now perform a throat swab rather than a nasal swab to complete the test.
EXCLUSIVE Distributer to USA, Canada and Mexico.
GLTA
$AYTU
Zip Code Changer.
GLTA
$AYTU
Very smart, and he got $29M from the FUND, to finance production and purchases.
GLTA
$AYTU
Good call.
GLTA
$AYTU
I just tweeted it to VP Mike Pence
GLTA
$AYTU
Are you serious?
GLTA
$AYTU
Aytu BioScience Inc. (AYTU) Resumed Trading
Dow Jones 3/10/20 2:03 PM ET
Aytu BioScience Inc. (AYTU) Paused due to volatility
Dow Jones 3/10/20 2:03 PM ET
Aytu BioScience Inc. (AYTU) Paused due to volatility
Dow Jones 3/10/20 1:53 PM ET
Aytu BioScience Inc. (AYTU) Resumed Trading
Dow Jones 3/10/20 1:52 PM ET
Aytu BioScience Inc. (AYTU) Resumed Trading
Dow Jones 3/10/20 1:42 PM ET
Aytu BioScience Inc. (AYTU) Paused due to volatility
Dow Jones 3/10/20 1:42 PM ET
Aytu BioScience Inc. (AYTU) Paused due to volatility
Dow Jones 3/10/20 1:37 PM ET
Aytu BioScience Inc. (AYTU) Resumed Trading
Dow Jones 3/10/20 1:36 PM ET
Aytu BioScience Inc. (AYTU) Resumed Trading
Dow Jones 3/10/20 1:26 PM ET
Aytu BioScience Inc. (AYTU) Paused due to volatility
Dow Jones 3/10/20 1:26 PM ET
Aytu BioScience Inc. (AYTU) Paused due to volatility
Dow Jones 3/10/20 1:21 PM ET
Thank you, the Real Crazy Kar.
GLTA
$AYTU
Well said, thanks.
Merger and acquisition, that is why they gave 600,000 shares to officers.
GLTA
$SAUC
$ZMRK
I second that.
GLTA
$ZMRK
$ZMRK
Hi Laster,
Bring it on.
I agree, there is still time to jump on this wagon.
GLTA
$ZMRK
$ZMRK
Yes we are. Looking forward to Monday morning.
GLTA
$ZMRK